The monoclonal antibody VYD2311 potently neutralizes dominant and emerging SARS-CoV-2 variants

Ian A. Mellis, Madeline Wu, Kristin Daniel, Hsiang Hong, Yicheng Guo, David D. Ho

Open source

DOI
10.1172/jci.insight.208557
Published
2026-08-11
Container
JCI Insight
Publisher
American Society for Clinical Investigation
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1172/jci.insight.208557,
  title = {The monoclonal antibody VYD2311 potently neutralizes dominant and emerging SARS-CoV-2 variants},
  author = {Ian A. Mellis and Madeline Wu and Kristin Daniel and Hsiang Hong and Yicheng Guo and David D. Ho},
  year = {2026},
  journal = {JCI Insight},
  doi = {10.1172/jci.insight.208557},
  url = {https://doi.org/10.1172/jci.insight.208557}
}

RIS

TY  - JOUR
TI  - The monoclonal antibody VYD2311 potently neutralizes dominant and emerging SARS-CoV-2 variants
AU  - Ian A. Mellis
AU  - Madeline Wu
AU  - Kristin Daniel
AU  - Hsiang Hong
AU  - Yicheng Guo
AU  - David D. Ho
PY  - 2026
JO  - JCI Insight
DO  - 10.1172/jci.insight.208557
UR  - https://doi.org/10.1172/jci.insight.208557
ER  - 

APA

Mellis, I. A., Wu, M., Daniel, K., Hong, H., Guo, Y., & Ho, D. D. (2026). The monoclonal antibody VYD2311 potently neutralizes dominant and emerging SARS-CoV-2 variants. JCI Insight. https://doi.org/10.1172/jci.insight.208557

Source records